A phase 1 trial of the oral DNA methyltransferase inhibitor CC‐486 and the histone deacetylase inhibitor romidepsin in advanced solid tumorsStéphanie Gaillard, Nilofer S. Azad, Michelle A. Rudek et al.|Cancer|2019Cited by 56